Will “Apifiny” be helpful in the diagnosis of prostate cancer?

The development-stage test known as Apifiny is a new type of test that its creators believe will help in the more accurate diagnosis of prostate cancer. Whether that is actually the case seems to be rather less certain as yet. … READ MORE …

MRI/TRUS fusion-guided biopsies and the diagnosis of prostate cancer

An important article by Siddiqui et al. appears in this week’s issue of the Journal of the American Medical Association. It deals with the experience of Dr. Peter Pinto and his colleagues in the diagnosis of prostate cancer in about 1,000 patients over the past few years. … READ MORE …

Prediction of the “real” risk of death from prostate cancer

A while ago now we first discussed research being done by Eric Feuer and others on what was initially being called the Cancer Survival Query System or CSQS. … READ MORE …

James Mohler talks prostate cancer on CureTalk

On Tuesday this week, Dr. James L. Mohler of Roswell Park Cancer Institute participated in an hour-long discussion on key issues related to the diagnosis and management of early stage prostate cancer. … READ MORE …

First and second biopsies and their diagnostic accuracy

A paper by Wong et al. published in December carries the title, “Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer.” … READ MORE …

PSA levels and eligibility for active surveillance

The general rule has been that only men with low-risk prostate cancer are suitable as possible candidates for active surveillance. Low risk is defined as a PSA < 10 ng/ml; a Gleason score of ≤ 6; and a clinical stage of ≤ T2aN0M0. … READ MORE …

To screen or not to screen: an Australian “discrete choice experiment”

The question of whether men should be regularly screened for risk of prostate cancer through the use of the PSA test is (at least) controversial … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,214 other followers